microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development

References

1. Lander, ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187–97. https://doi.org/10.1038/nature09792.Search in Google Scholar PubMed

2. Jacob, R, Zander, S, Gutschner, T. The dark side of the epitranscriptome: chemical modifications in long non-coding RNAs. Int J Mol Sci 2017;18:2387. https://doi.org/10.3390/ijms18112387.Search in Google Scholar PubMed PubMed Central

3. Hu, G, Niu, F, Humburg, BA, Liao, K, Bendi, S, Callen, S, et al.. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget 2018;9:18648. https://doi.org/10.18632/oncotarget.24307.Search in Google Scholar PubMed PubMed Central

4. Butler, AA, Webb, WM, Lubin, FD. Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics 2016;8:135–51. https://doi.org/10.2217/epi.15.79.Search in Google Scholar PubMed PubMed Central

5. Ling, H, Fabbri, M, Calin, GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013;12:847. https://doi.org/10.1038/nrd4140.Search in Google Scholar PubMed PubMed Central

6. Almeida, MI, Reis, RM, Calin, GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res Fund Mol Mech Mutagen 2011;717:1–8. https://doi.org/10.1016/j.mrfmmm.2011.03.009.Search in Google Scholar PubMed

7. Iorio, MV, Visone, R, Di Leva, G, Donati, V, Petrocca, F, Casalini, P, et al.. MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699–707. https://doi.org/10.1158/0008-5472.can-07-1936.Search in Google Scholar

8. Liu, B, Li, J, Cairns, MJ. Identifying miRNAs, targets and functions. Briefings Bioinf 2014;15:1–19. https://doi.org/10.1093/bib/bbs075.Search in Google Scholar PubMed PubMed Central

9. Schanen, BC, Li, X. Transcriptional regulation of mammalian miRNA genes. Genomics 2011;97:1–6. https://doi.org/10.1016/j.ygeno.2010.10.005.Search in Google Scholar PubMed PubMed Central

10. Ha, M, Kim, VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014;15:509–24. https://doi.org/10.1038/nrm3838.Search in Google Scholar PubMed

11. Treiber, T, Treiber, N, Meister, G. Regulation of microRNA biogenesis and function. Thromb Haemostasis 2012;107:605–10. https://doi.org/10.1160/th11-12-0836.Search in Google Scholar

12. Felekkis, K, Touvana, E, Stefanou, C, Deltas, C. microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 2010;14:236.Search in Google Scholar

13. Kian, R, Moradi, S, Ghorbian, S. Role of components of microRNA machinery in carcinogenesis. Exp Oncol 2018;40:2–9. https://doi.org/10.31768/2312-8852.2018.40(1):2-9.10.31768/2312-8852.2018.40(1):2-9Search in Google Scholar

14. Aslam, MI, Patel, M, Singh, B, Jameson, JS, Pringle, JH. MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application. J Transl Med 2012;10:1–14. https://doi.org/10.1186/1479-5876-10-128.Search in Google Scholar PubMed PubMed Central

15. Cambronne, XA, Shen, R, Auer, PL, Goodman, RH. Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach. Proc Natl Acad Sci USA 2012;109:20473–8. https://doi.org/10.1073/pnas.1218887109.Search in Google Scholar PubMed PubMed Central

16. Slobodin, B, Han, R, Calderone, V, Vrielink, JAO, Loayza-Puch, F, Elkon, R, et al.. Transcription impacts the efficiency of mRNA translation via co-transcriptional N6-adenosine methylation. Cell 2017;169:326–37. e12. https://doi.org/10.1016/j.cell.2017.03.031.Search in Google Scholar PubMed PubMed Central

17. Wilson, RC, Tambe, A, Kidwell, MA, Noland, CL, Schneider, CP, Doudna, JA. Dicer-TRBP complex formation ensures accurate mammalian microRNA biogenesis. Mol Cell 2015;57:397–407. https://doi.org/10.1016/j.molcel.2014.11.030.Search in Google Scholar PubMed PubMed Central

18. Ellwanger, JH, Zambra, FMB, Guimarães, RL, Chies, JAB. MicroRNA-related polymorphisms in infectious diseases—tiny changes with a huge impact on viral infections and potential clinical applications. Front Immunol 2018;9:1316. https://doi.org/10.3389/fimmu.2018.01316.Search in Google Scholar PubMed PubMed Central

19. Kaczmarek, JC, Kowalski, PS, Anderson, DG. Advances in the delivery of RNA therapeutics: from concept to clinical reality. Genome Med 2017;9:60. https://doi.org/10.1186/s13073-017-0450-0.Search in Google Scholar PubMed PubMed Central

20. Li, H, Yang, Y, Hong, W, Huang, M, Wu, M, Zhao, X. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Targeted Ther 2020;5:1–23. https://doi.org/10.1038/s41392-019-0089-y.Search in Google Scholar PubMed PubMed Central

21. Moreno-Moya, JM, Vilella, F, Simón, C. MicroRNA: key gene expression regulators. Fertil Steril 2014;101:1516–23. https://doi.org/10.1016/j.fertnstert.2013.10.042.Search in Google Scholar PubMed

22. Ortiz-Quintero, B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif 2016;49:281–303. https://doi.org/10.1111/cpr.12262.Search in Google Scholar PubMed PubMed Central

23. Lei, W, Luo, Y, Lei, W, Luo, Y, Yan, K, Zhao, S, et al.. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369–74. https://doi.org/10.1080/03009740902758875.Search in Google Scholar PubMed

24. Cui, C, Cui, Q. The relationship of human tissue microRnAs with those from body fluids. Sci Rep 2020;10:1–7. https://doi.org/10.1038/s41598-020-62534-6.Search in Google Scholar PubMed PubMed Central

25. Fehlmann, T, Ludwig, N, Backes, C, Meese, E, Keller, A. Distribution of microRNA biomarker candidates in solid tissues and body fluids. RNA Biol 2016;13:1084–8. https://doi.org/10.1080/15476286.2016.1234658.Search in Google Scholar PubMed PubMed Central

26. Ludwig, N, Leidinger, P, Becker, K, Backes, C, Fehlmann, T, Pallasch, C, et al.. Distribution of miRNA expression across human tissues. Nucleic Acids Res 2016;44:3865–77. https://doi.org/10.1093/nar/gkw116.Search in Google Scholar PubMed PubMed Central

27. Grifone, TJ. Cell polarity and oncogenesis: common mutations contribute to altered cellular polarity and promote malignancy. Nucleus 2020;63:91–106. https://doi.org/10.1007/s13237-020-00313-4.Search in Google Scholar

28. Fouad, YA, Aanei, C. Revisiting the hallmarks of cancer. Am J Cancer Res 2017;7:1016.Search in Google Scholar

29. Jiramongkol, Y, Lam, EW-F. FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev 2020;39:681–709. https://doi.org/10.1007/s10555-020-09883-w.Search in Google Scholar PubMed PubMed Central

30. Svoronos, AA, Engelman, DM, Slack, FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res 2016;76:3666–70. https://doi.org/10.1158/0008-5472.can-16-0359.Search in Google Scholar

31. Medina, PP, Nolde, M, Slack, FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010;467:86–90. https://doi.org/10.1038/nature09284.Search in Google Scholar PubMed

32. Garzon, R, Marcucci, G, Croce, CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775–89. https://doi.org/10.1038/nrd3179.Search in Google Scholar PubMed PubMed Central

33. Saito, Y, Liang, G, Egger, G, Friedman, JM, Chuang, JC, Coetzee, GA, et al.. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9:435–43. https://doi.org/10.1016/j.ccr.2006.04.020.Search in Google Scholar PubMed

34. Visone, R, Russo, L, Pallante, P, De Martino, I, Ferraro, A, Leone, V, et al.. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007;14:791–8. https://doi.org/10.1677/erc-07-0129.Search in Google Scholar

35. Schaefer, A, Jung, M, Kristiansen, G, Lein, M, Schrader, M, Miller, K, et al.. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urol Oncol 2010;28:4–13.10.1016/j.urolonc.2008.10.021Search in Google Scholar PubMed

36. Arif, K, Elliott, EK, Haupt, LM, Griffiths, LR. Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets. Cancers 2020;12:2922. https://doi.org/10.3390/cancers12102922.Search in Google Scholar PubMed PubMed Central

37. Leichter, AL, Sullivan, MJ, Eccles, MR, Chatterjee, A. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Mol Cancer 2017;16:15. https://doi.org/10.1186/s12943-017-0584-0.Search in Google Scholar PubMed PubMed Central

38. Zhang, Y, Yang, Z, Wu, J. Signaling pathways and preimplantation development of mammalian embryos. FEBS J 2007;274:4349–59. https://doi.org/10.1111/j.1742-4658.2007.05980.x.Search in Google Scholar PubMed

39. Kumar, B, Rosenberg, AZ, Choi, SM, Fox-Talbot, K, De Marzo, AM, Nonn, L, et al.. Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. Sci Rep 2018;8:1–13. https://doi.org/10.1038/s41598-018-25320-z.Search in Google Scholar PubMed PubMed Central

40. To, KK, Tong, CW, Wu, M, Cho, WC. MicroRNAs in the prognosis and therapy of colorectal cancer: from bench to bedside. World J Gastroenterol 2018;24:2949. https://doi.org/10.3748/wjg.v24.i27.2949.Search in Google Scholar PubMed PubMed Central

41. Condrat, CE, Thompson, DC, Barbu, MG, Bugnar, OL, Boboc, A, Cretoiu, D, et al.. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells 2020;9:276. https://doi.org/10.3390/cells9020276.Search in Google Scholar PubMed PubMed Central

42. Mahmoudian-Sani, M-R, Mehri-Ghahfarrokhi, A, Asadi-Samani, M, Mobini, G-R. Serum miRNAs as biomarkers for the diagnosis and prognosis of thyroid cancer: a comprehensive review of the literature. Eur Thyroid J 2017;6:171–7. https://doi.org/10.1159/000468520.Search in Google Scholar PubMed PubMed Central

43. Macha, AM, Seshacharyulu, P, Ram Krishn, S, Pai, P, Rachagani, S, Jain, M, et al.. MicroRNAs (miRNAs) as biomarker (s) for prognosis and diagnosis of gastrointestinal (GI) cancers. Curr Pharmaceut Des 2014;20:5287–97. https://doi.org/10.2174/1381612820666140128213117.Search in Google Scholar PubMed PubMed Central

44. Allegra, A, Alonci, A, Campo, S, Penna, G, Petrungaro, A, Gerace, D, et al.. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 2012;41:1897–912. https://doi.org/10.3892/ijo.2012.1647.Search in Google Scholar PubMed

45. Niveditha, D, Jasoria, M, Narayan, J, Majumder, S, Mukherjee, S, Chowdhury, R, et al.. Common and Unique microRnAs in Multiple carcinomas Regulate Similar network of pathways to Mediate cancer progression. Sci Rep 2020;10:1–11. https://doi.org/10.1038/s41598-020-59142-9.Search in Google Scholar PubMed PubMed Central

46. Zhang, X, Cui, R, Cui, M, Wang, H, Yao, X, Zhang, D, et al.. Circulating MicroRNAs in cancer: potential and challenge. Front Genet 2019;10:626. https://doi.org/10.3389/fgene.2019.00626.Search in Google Scholar PubMed PubMed Central

47. Qu, Y, Zhang, H, Sun, W, Han, Y, Li, S, Qu, Y, et al.. Micro RNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2. Cancer Sci 2018;109:618–28. https://doi.org/10.1111/cas.13472.Search in Google Scholar PubMed PubMed Central

48. Liu, L, Ren, W, Chen, K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem 2017;41:1981–92. https://doi.org/10.1159/000475277.Search in Google Scholar PubMed

49. Li, GC, Cao, XY, Li, YN, Qiu, YY, Li, YN, Liu, XJ, et al.. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2. J Cell Physiol 2018;233:7379–90. https://doi.org/10.1002/jcp.26574.Search in Google Scholar PubMed

50. Zhu, Y, Gu, J, Li, Y, Peng, C, Shi, M, Wang, X, et al.. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. Cancer Lett 2018;412:59–68. https://doi.org/10.1016/j.canlet.2017.09.044.Search in Google Scholar PubMed

51. Croce, CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704–14. https://doi.org/10.1038/nrg2634.Search in Google Scholar PubMed PubMed Central

52. Feng, Z, Zhang, C, Wu, R, Hu, W. Tumor suppressor p53 meets microRNAs. J Mol Cell Biol 2011;3:44–50. https://doi.org/10.1093/jmcb/mjq040.Search in Google Scholar PubMed PubMed Central

53. Lin, S, Gregory, RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 2015;15:321–33. https://doi.org/10.1038/nrc3932.Search in Google Scholar PubMed PubMed Central

54. Liu, H, Lei, C, He, Q, Pan, Z, Xiao, D, Tao, Y. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer 2018;17:64. https://doi.org/10.1186/s12943-018-0765-5.Search in Google Scholar PubMed PubMed Central

55. Mognato, M, Celotti, L. MicroRNAs used in combination with anti-cancer treatments can enhance therapy efficacy. Mini Rev Med Chem 2015;15:1052–62. https://doi.org/10.2174/1389557515666150709115355.Search in Google Scholar PubMed PubMed Central

56. Si, W, Shen, J, Zheng, H, Fan, W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenet 2019;11:25. https://doi.org/10.1186/s13148-018-0587-8.Search in Google Scholar PubMed PubMed Central

57. Wang, H. MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci 2020;21:5353. https://doi.org/10.3390/ijms21155353.Search in Google Scholar PubMed PubMed Central

58. Yang, BF, Lu, YJ, Wang, ZG. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin Exp Pharmacol Physiol 2009;36:951–60. https://doi.org/10.1111/j.1440-1681.2009.05245.x.Search in Google Scholar PubMed

59. Florczuk, M, Szpechcinski, A, Chorostowska-Wynimko, J. miRNAs as biomarkers and therapeutic targets in non-small cell lung cancer: current perspectives. Targeted Oncol 2017;12:179–200. https://doi.org/10.1007/s11523-017-0478-5.Search in Google Scholar PubMed

60. Abd-Aziz, N, Kamaruzman, NI, Poh, CL. Development of MicroRNAs as potential therapeutics against cancer. J Oncol 2020;2020:8029721.10.1155/2020/8029721Search in Google Scholar PubMed PubMed Central

61. Iorio, MV, Croce, CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012;4:143–59. https://doi.org/10.1002/emmm.201100209.Search in Google Scholar PubMed PubMed Central

62. Lima, JF, Cerqueira, L, Figueiredo, C, Oliveira, C, Azevedo, NF. Anti-miRNA oligonucleotides: a comprehensive guide for design. RNA Biol 2018;15:338–52. https://doi.org/10.1080/15476286.2018.1445959.Search in Google Scholar PubMed PubMed Central

63. Xu, J, Zeng, JQ, Wan, G, Hu, GB, Yan, H, Ma, LX. Construction of siRNA/miRNA expression vectors based on a one-step PCR process. BMC Biotechnol 2009;9:53. https://doi.org/10.1186/1472-6750-9-53.Search in Google Scholar PubMed PubMed Central

64. Baglìo, SR, Devescovi, V, Granchi, D, Baldini, N. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene 2013;527:321–31. https://doi.org/10.1016/j.gene.2013.06.021.Search in Google Scholar PubMed

65. Moi, L, Braaten, T, Al-Shibli, K, Lund, E, Busund, L-TR. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study. J Transl Med 2019;17:1–20. https://doi.org/10.1186/s12967-019-2086-x.Search in Google Scholar PubMed PubMed Central

66. Bandres, E, Bitarte, N, Arias, F, Agorreta, J, Fortes, P, Agirre, X, et al.. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009;15:2281–90. https://doi.org/10.1158/1078-0432.ccr-08-1818.Search in Google Scholar

67. Müller, S, Janke, F, Dietz, S, Sültmann, H. Circulating MicroRNAs as potential biomarkers for lung cancer. Recent Results Cancer Res 2020;215:299–318. https://doi.org/10.1007/978-3-030-26439-0_16.Search in Google Scholar PubMed

68. Yuan, H-L, Wang, T, Zhang, K-H. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer. Onco Targets Ther 2018;11:3891. https://doi.org/10.2147/ott.s156921.Search in Google Scholar PubMed PubMed Central

69. Park, NJ, Zhou, H, Elashoff, D, Henson, BS, Kastratovic, DA, Abemayor, E, et al.. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15:5473–7. https://doi.org/10.1158/1078-0432.ccr-09-0736.Search in Google Scholar PubMed PubMed Central

70. Liu, X-G, Zhu, W-Y, Huang, Y-Y, Ma, L-N, Zhou, S-Q, Wang, Y-K, et al.. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012;29:618–26. https://doi.org/10.1007/s12032-011-9923-y.Search in Google Scholar PubMed

71. Toiyama, Y, Takahashi, M, Hur, K, Nagasaka, T, Tanaka, K, Inoue, Y, et al.. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013;105:849–59. https://doi.org/10.1093/jnci/djt101.Search in Google Scholar PubMed PubMed Central

72. Lawrie, CH, Gal, S, Dunlop, HM, Pushkaran, B, Liggins, AP, Pulford, K, et al.. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672–5. https://doi.org/10.1111/j.1365-2141.2008.07077.x.Search in Google Scholar PubMed

73. Sozzi, G, Boeri, M, Rossi, M, Verri, C, Suatoni, P, Bravi, F, et al.. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 2014;32:768. https://doi.org/10.1200/jco.2013.50.4357.Search in Google Scholar PubMed PubMed Central

74. Schwarzenbach, H, Nishida, N, Calin, GA, Pantel, K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 2014;11:145. https://doi.org/10.1038/nrclinonc.2014.5.Search in Google Scholar PubMed

75. Wang, P, Zhuang, L, Zhang, J, Fan, J, Luo, J, Chen, H, et al.. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol Oncol 2013;7:334–45. https://doi.org/10.1016/j.molonc.2012.10.011.Search in Google Scholar PubMed PubMed Central

76. Kroh, EM, Parkin, RK, Mitchell, PS, Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010;50:298–301. https://doi.org/10.1016/j.ymeth.2010.01.032.Search in Google Scholar PubMed PubMed Central

77. Wu, X, Somlo, G, Yu, Y, Palomares, MR, Li, AX, Zhou, W, et al.. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med 2012;10:1–10. https://doi.org/10.1186/1479-5876-10-42.Search in Google Scholar PubMed PubMed Central

78. Alajez, NM, Shi, W, Wong, D, Lenarduzzi, M, Waldron, J, Weinreb, I, et al.. Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway. Oncotarget 2012;3:1641. https://doi.org/10.18632/oncotarget.785.Search in Google Scholar PubMed PubMed Central

79. Oliveira, AC, Bovolenta, LA, Nachtigall, PG, Herkenhoff, ME, Lemke, N, Pinhal, D. Combining results from distinct MicroRNA target prediction tools enhances the performance of analyses. Front Genet 2017;8:59. https://doi.org/10.3389/fgene.2017.00059.Search in Google Scholar PubMed PubMed Central

80. Martin, EM, Fry, RC. Environmental influences on the epigenome: exposure-associated DNA methylation in human populations. Annu Rev Publ Health 2018;39:309–33. https://doi.org/10.1146/annurev-publhealth-040617-014629.Search in Google Scholar PubMed

81. Loginov, V, Rykov, S, Fridman, M, Braga, E. Methylation of miRNA genes and oncogenesis. Biochemistry 2015;80:145–62. https://doi.org/10.1134/s0006297915020029.Search in Google Scholar PubMed

82. Joehanes, R, Just, AC, Marioni, RE, Pilling, LC, Reynolds, LM, Mandaviya, PR, et al.. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet 2016;9:436–47. https://doi.org/10.1161/circgenetics.116.001506.Search in Google Scholar PubMed PubMed Central

83. Maruyama, R, Choudhury, S, Kowalczyk, A, Bessarabova, M, Beresford-Smith, B, Conway, T, et al.. Epigenetic regulation of cell type–specific expression patterns in the human mammary epithelium. PLoS Genet 2011;7:e1001369. https://doi.org/10.1371/journal.pgen.1001369.Search in Google Scholar PubMed PubMed Central

84. Lamadrid-Romero, M, Solís, K, Cruz-Reséndiz, M, Pérez, J, Díaz, N, Flores-Herrera, H, et al.. Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy. Neurosci Res 2018;130:8–22. https://doi.org/10.1016/j.neures.2017.08.003.Search in Google Scholar PubMed

85. Wang, L, Fan, H, Zhou, L, Wu, Y, Lu, H, Luo, J. Altered expression of PGC-1α and PDX1 and their methylation status are associated with fetal glucose metabolism in gestational diabetes mellitus. Biochem Biophys Res Commun 2018;501:300–6. https://doi.org/10.1016/j.bbrc.2018.05.010.Search in Google Scholar PubMed

86. Chaput, N, Théry, C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011;33:419–40.10.1007/s00281-010-0233-9Search in Google Scholar PubMed

87. Chiarugi, P, Cirri, P. Metabolic exchanges within tumor microenvironment. Cancer Lett 2016;380:272–80. https://doi.org/10.1016/j.canlet.2015.10.027.Search in Google Scholar PubMed

88. Tkach, M, Théry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 2016;164:1226–32. https://doi.org/10.1016/j.cell.2016.01.043.Search in Google Scholar PubMed

89. Sanz-Rubio, D, Martin-Burriel, I, Gil, A, Cubero, P, Forner, M, Khalyfa, A, et al.. Stability of circulating exosomal miRNAs in healthy subjects. Sci Rep 2018;8:1–10. https://doi.org/10.1038/s41598-018-28748-5.Search in Google Scholar PubMed PubMed Central

90. Saikolappan, S, Kumar, B, Shishodia, G, Koul, S, Koul, HK. Reactive oxygen species and cancer: a complex interaction. Cancer Lett 2019;452:132–43. https://doi.org/10.1016/j.canlet.2019.03.020.Search in Google Scholar PubMed

91. Trachootham, D, Alexandre, J, Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009;8:579–91. https://doi.org/10.1038/nrd2803.Search in Google Scholar PubMed

92. Parvez, S, Long, MJ, Poganik, JR, Aye, Y. Redox signaling by reactive electrophiles and oxidants. Chem Rev 2018;118:8798–888. https://doi.org/10.1021/acs.chemrev.7b00698.Search in Google Scholar PubMed PubMed Central

93. He, F, Zuo, L. Redox roles of reactive oxygen species in cardiovascular diseases. Int J Mol Sci 2015;16:27770–80. https://doi.org/10.3390/ijms161126059.Search in Google Scholar PubMed PubMed Central

94. El Banna, N, Hatem, E, Heneman-Masurel, A, Léger, T, Baïlle, D, Vernis, L, et al.. Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: involvement in vitamin C-induced breast cancer cell death. Redox Biol 2019;26:101290. https://doi.org/10.1016/j.redox.2019.101290.Search in Google Scholar PubMed PubMed Central

95. Wang, K, Jiang, J, Lei, Y, Zhou, S, Wei, Y, Huang, C. Targeting metabolic–redox circuits for cancer therapy. Trends Biochem Sci 2019;44:401–14. https://doi.org/10.1016/j.tibs.2019.01.001.Search in Google Scholar PubMed

96. Wilczynska, A, Bushell, M. The complexity of miRNA-mediated repression. Cell Death Differ 2015;22:22–33. https://doi.org/10.1038/cdd.2014.112.Search in Google Scholar PubMed PubMed Central

97. Iqbal, MA, Arora, S, Prakasam, G, Calin, GA, Syed, MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspect Med 2019;70:3–20. https://doi.org/10.1016/j.mam.2018.07.003.Search in Google Scholar PubMed

98. He, J, Jiang, B-H. Interplay between reactive oxygen species and microRNAs in cancer. Curr Pharmacol Rep 2016;2:82–90. https://doi.org/10.1007/s40495-016-0051-4.Search in Google Scholar PubMed PubMed Central

99. Zhang, L, Sun, Z-J, Bian, Y, Kulkarni, AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett 2013;331:230–8. https://doi.org/10.1016/j.canlet.2013.01.003.Search in Google Scholar PubMed PubMed Central

100. Yeh, YM, Chuang, CM, Chao, KC, Wang, LH. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer 2013;133:867–78. https://doi.org/10.1002/ijc.28086.Search in Google Scholar PubMed

101. Yang, M, Yao, Y, Eades, G, Zhang, Y, Zhou, Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011;129:983–91. https://doi.org/10.1007/s10549-011-1604-1.Search in Google Scholar PubMed PubMed Central

102. Singh, B, Ronghe, AM, Chatterjee, A, Bhat, NK, Bhat, HK. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis 2013;34:1165–72. https://doi.org/10.1093/carcin/bgt026.Search in Google Scholar PubMed PubMed Central

103. Chen, Y-F, Wei, Y-Y, Yang, C-C, Liu, C-J, Yeh, L-Y, Chou, C-H, et al.. miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A. Redox Biol 2019;22:101140. https://doi.org/10.1016/j.redox.2019.101140.Search in Google Scholar PubMed PubMed Central

104. Yin, Y, Liu, H, Xu, J, Shi, D, Zhai, L, Liu, B, et al.. miR-144-3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2. Oncol Rep 2018;40:3479–88. https://doi.org/10.3892/or.2018.6772.Search in Google Scholar PubMed

105. Li, S, Chen, T, Zhong, Z, Wang, Y, Li, Y, Zhao, X. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep 2012;5:949–54. https://doi.org/10.3892/mmr.2012.779.Search in Google Scholar PubMed PubMed Central

106. Petrelli, A, Perra, A, Cora, D, Sulas, P, Menegon, S, Manca, C, et al.. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). Hepatology 2014;59:228–41. https://doi.org/10.1002/hep.26616.Search in Google Scholar PubMed

107. Tu, H, Sun, H, Lin, Y, Ding, J, Nan, K, Li, Z, et al.. Oxidative stress upregulates PDCD4 expression in patients with gastric cancer via miR-21. Curr Pharmaceut Des 2014;20:1917–23. https://doi.org/10.2174/13816128113199990547.Search in Google Scholar PubMed

108. Cui, Y, Kai’e She, DT, Zhang, P, Xin, X. miR-146a inhibits proliferation and enhances chemosensitivity in epithelial ovarian cancer via reduction of SOD2. Oncol Res 2016;23:275. https://doi.org/10.3727/096504016x14562725373798.Search in Google Scholar PubMed PubMed Central

109. Patel, GK, Khan, MA, Bhardwaj, A, Srivastava, SK, Zubair, H, Patton, MC, et al.. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK. Br J Cancer 2017;116:609–19. https://doi.org/10.1038/bjc.2017.18.Search in Google Scholar PubMed PubMed Central

110. Meng, X, Wu, J, Pan, C, Wang, H, Ying, X, Zhou, Y, et al.. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology 2013;145:426–36. e6. https://doi.org/10.1053/j.gastro.2013.04.004.Search in Google Scholar PubMed

111. Liu, L, Wang, Y, Bai, R, Yang, K, Tian, Z. Erratum: MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation. Oncogenesis 2017;6:e318–e. https://doi.org/10.1038/oncsis.2017.20.Search in Google Scholar PubMed PubMed Central

112. Eastlack, SC, Dong, S, Ivan, C, Alahari, SK. Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer. Mol Cancer 2018;17:1–16. https://doi.org/10.1186/s12943-018-0851-8.Search in Google Scholar PubMed PubMed Central

113. Xiong, Y, Fang, JH, Yun, JP, Yang, J, Zhang, Y, Jia, WH, et al.. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010;51:836–45. https://doi.org/10.1002/hep.23380.Search in Google Scholar PubMed

114. Yu, Y, Yang, L, Zhao, M, Zhu, S, Kang, R, Vernon, P, et al.. Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia 2012;26:1752–60. https://doi.org/10.1038/leu.2012.65.Search in Google Scholar PubMed

115. Kao, Y-Y, Chou, C-H, Yeh, L-Y, Chen, Y-F, Chang, K-W, Liu, C-J, et al.. MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma. Cancer Lett 2019;456:40–8. https://doi.org/10.1016/j.canlet.2019.04.028.Search in Google Scholar PubMed

116. Lei, W, Wang, S, Yang, C, Huang, X, Chen, Z, He, W, et al.. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma. Sci Rep 2016;6:1–11. https://doi.org/10.1038/srep32174.Search in Google Scholar PubMed PubMed Central

117. Fiori, ME, Villanova, L, Barbini, C, De Angelis, ML, De Maria, R. miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2. Cell Death Dis 2018;9:1–13. https://doi.org/10.1038/s41419-017-0080-x.Search in Google Scholar PubMed PubMed Central

118. Taguchi, K, Yamamoto, M. The KEAP1–NRF2 system in cancer. Front Oncology 2017;7:85. https://doi.org/10.3389/fonc.2017.00085.Search in Google Scholar PubMed PubMed Central

119. Ayers, D, Baron, B, Hunter, T. miRNA influences in NRF2 pathway interactions within cancer models. J Nucleic Acids 2015;2015:143636. https://doi.org/10.1155/2015/143636.Search in Google Scholar PubMed PubMed Central

120. Itoh, K, Mimura, J, Yamamoto, M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 2010;13:1665–78. https://doi.org/10.1089/ars.2010.3222.Search in Google Scholar PubMed

121. Eades, G, Yang, M, Yao, Y, Zhang, Y, Zhou, Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011;286:40725–33. https://doi.org/10.1074/jbc.m111.275495.Search in Google Scholar PubMed PubMed Central

122. Han, Y, Kim, B, Cho, U, Park, IS, Kim, SI, Dhanasekaran, DN, et al.. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene 2019;38:7089–105. https://doi.org/10.1038/s41388-019-0949-5.Search in Google Scholar PubMed

123. Chen, Z, Li, Y, Zhang, H, Huang, P, Luthra, R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010;29:4362–8. https://doi.org/10.1038/onc.2010.193.Search in Google Scholar PubMed

124. Tagscherer, KE, Fassl, A, Sinkovic, T, Richter, J, Schecher, S, Macher-Goeppinger, S, et al.. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int 2016;16:1–12. https://doi.org/10.1186/s12935-016-0321-6.Search in Google Scholar PubMed PubMed Central

125. Orang, AV, Petersen, J, McKinnon, RA, Michael, MZ. Micromanaging aerobic respiration and glycolysis in cancer cells. Mol Metabol 2019;23:98–126. https://doi.org/10.1016/j.molmet.2019.01.014.Search in Google Scholar PubMed PubMed Central

126. Fan, S, Tian, T, Chen, W, Lv, X, Lei, X, Zhang, H, et al.. Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating mitochondrial transcription. Cancer Res 2019;79:1069–84. https://doi.org/10.1158/0008-5472.can-18-2505.Search in Google Scholar PubMed PubMed Central

127. Xu, Z, Zhang, Y, Ding, J, Hu, W, Tan, C, Wang, M, et al.. miR-17-3p downregulates mitochondrial antioxidant enzymes and enhances the radiosensitivity of prostate cancer cells. Mol Ther Nucleic Acids 2018;13:64–77. https://doi.org/10.1016/j.omtn.2018.08.009.Search in Google Scholar PubMed PubMed Central

128. Bhattacharyya, A, Chattopadhyay, R, Mitra, S, Crowe, SE. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 2014;94:329–54. https://doi.org/10.1152/physrev.00040.2012.Search in Google Scholar PubMed PubMed Central

129. Janssen, A, Bosmanvan, CDW, Oostendorp-van de Ruit, MM, Kubben, FJ, Griffioen, G, Lamers, CB, et al.. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res 2000;6:3183–92.Search in Google Scholar

130. Lin, J, Chuang, C-C, Zuo, L. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets. Oncotarget 2017;8:17328. https://doi.org/10.18632/oncotarget.14461.Search in Google Scholar PubMed PubMed Central

131. Wang, Q, Chen, W, Bai, L, Chen, W, Padilla, MT, Lin, AS, et al.. Receptor-interacting protein 1 increases chemoresistance by maintaining inhibitor of apoptosis protein levels and reducing reactive oxygen species through a microRNA-146a-mediated catalase pathway. J Biol Chem 2014;289:5654–63. https://doi.org/10.1074/jbc.m113.526152.Search in Google Scholar PubMed PubMed Central

132. Nallamshetty, S, Chan, SY, Loscalzo, J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013;64:20–30. https://doi.org/10.1016/j.freeradbiomed.2013.05.022.Search in Google Scholar PubMed PubMed Central

133. Jin, F, Yang, R, Wei, Y, Wang, D, Zhu, Y, Wang, X, et al.. HIF-1α-induced miR-23a∼27a∼24 cluster promotes colorectal cancer progression via reprogramming metabolism. Cancer Lett 2019;440:211–22. https://doi.org/10.1016/j.canlet.2018.10.025.Search in Google Scholar PubMed

134. Wong, CCL, Tse, APW, Huang, YP, Zhu, YT, Chiu, DKC, Lai, RKH, et al.. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology 2014;60:1645–58. https://doi.org/10.1002/hep.27320.Search in Google Scholar PubMed

135. Blick, C, Ramachandran, A, McCormick, R, Wigfield, S, Cranston, D, Catto, J, et al.. Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis. Br J Cancer 2015;113:634–44. https://doi.org/10.1038/bjc.2015.203.Search in Google Scholar PubMed PubMed Central

136. Shang, Y, Chen, H, Ye, J, Wei, X, Liu, S, Wang, R. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells. Exp Cell Res 2017;360:243–56. https://doi.org/10.1016/j.yexcr.2017.09.014.Search in Google Scholar PubMed

137. Kai, AKL, Chan, LK, Lo, RCL, Lee, JMF, Wong, CCL, Wong, JCM, et al.. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology 2016;64:473–87. https://doi.org/10.1002/hep.28577.Search in Google Scholar PubMed PubMed Central

138. Yue, H, Liu, L, Song, Z. miR-212 regulated by HIF-1α promotes the progression of pancreatic cancer. Exp Ther Med 2019;17:2359–65. https://doi.org/10.3892/etm.2019.7213.Search in Google Scholar PubMed PubMed Central

139. He, C, Wang, L, Zhang, J, Xu, H. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer. Mol Cancer 2017;16:1–14. https://doi.org/10.1186/s12943-017-0603-1.Search in Google Scholar PubMed PubMed Central

140. Seok, J-K, Lee, SH, Kim, MJ, Lee, Y-M. MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res 2014;42:8062–72. https://doi.org/10.1093/nar/gku515.Search in Google Scholar PubMed PubMed Central

141. Niu, Y, Jin, Y, Deng, S-C, Deng, S-J, Zhu, S, Liu, Y, et al.. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene 2018;37:1743–58. https://doi.org/10.1038/s41388-017-0082-2.Search in Google Scholar PubMed

142. Yang, H, Li, TW, Peng, J, Tang, X, Ko, KS, Xia, M, et al.. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology 2011;141:378–88. e4. https://doi.org/10.1053/j.gastro.2011.03.044.Search in Google Scholar PubMed PubMed Central

143. Zhu, S, He, C, Deng, S, Cui, S, Zeng, Z, Liu, M, et al.. MiR-548an, transcriptionally downregulated by HIF1α/HDAC1, suppresses tumorigenesis of pancreatic cancer by targeting vimentin expression. Mol Cancer Therapeut 2016;15:2209–19. https://doi.org/10.1158/1535-7163.mct-15-0877.Search in Google Scholar

144. Sampath, D, Liu, C, Vasan, K, Sulda, M, Puduvalli, VK, Wierda, WG, et al.. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 2012;119:1162–72. https://doi.org/10.1182/blood-2011-05-351510.Search in Google Scholar PubMed PubMed Central

145. Singh, A, Happel, C, Manna, SK, Acquaah-Mensah, G, Carrerero, J, Kumar, S, et al.. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest 2013;123:2921–34. https://doi.org/10.1172/jci66353.Search in Google Scholar

146. Hong, J, Wang, Y, Hu, B-C, Xu, L, Liu, J-Q, Chen, M-H, et al.. Transcriptional downregulation of microRNA-19a by ROS production and NF-κB deactivation governs resistance to oxidative stress-initiated apoptosis. Oncotarget 2017;8:70967. https://doi.org/10.18632/oncotarget.20235.Search in Google Scholar PubMed PubMed Central

147. Madhyastha, R, Madhyastha, H, Pengjam, Y, Nakajima, Y, Omura, S, Maruyama, M. NFkappaB activation is essential for miR-21 induction by TGFβ1 in high glucose conditions. Biochem Biophys Res Commun 2014;451:615–21. https://doi.org/10.1016/j.bbrc.2014.08.035.Search in Google Scholar PubMed

148. Wang, H, Garzon, R, Sun, H, Ladner, KJ, Singh, R, Dahlman, J, et al.. NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008;14:369–81. https://doi.org/10.1016/j.ccr.2008.10.006.Search in Google Scholar PubMed PubMed Central

149. Binker-Cosen, MJ, Richards, D, Oliver, B, Gaisano, HY, Binker, MG, Cosen-Binker, LI. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4/ROS/NF-κB/MMP-9 signaling pathway. Biochem Biophys Res Commun 2017;484:152–8. https://doi.org/10.1016/j.bbrc.2017.01.051.Search in Google Scholar PubMed

150. Xu, Q, Liu, L, Yin, Y, He, J, Li, Q, Qian, X, et al.. Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression. Oncogene 2015;34:5482–93. https://doi.org/10.1038/onc.2015.6.Search in Google Scholar PubMed

151. Bakirtzi, K, Hatziapostolou, M, Karagiannides, I, Polytarchou, C, Jaeger, S, Iliopoulos, D, et al.. Neurotensin signaling activates microRNAs-21 and-155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology 2011;141:1749–61. e1. https://doi.org/10.1053/j.gastro.2011.07.038.Search in Google Scholar PubMed PubMed Central

152. Ahir, M, Bhattacharya, S, Karmakar, S, Mukhopadhyay, A, Mukherjee, S, Ghosh, S, et al.. Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells. Biomaterials 2016;76:115–32. https://doi.org/10.1016/j.biomaterials.2015.10.044.Search in Google Scholar PubMed

153. Yuan, P, He, X-H, Rong, Y-F, Cao, J, Li, Y, Hu, Y-P, et al.. KRAS/NF-κB/YY1/miR-489 signaling axis controls pancreatic cancer metastasis. Cancer Res 2017;77:100–11. https://doi.org/10.1158/0008-5472.can-16-1898.Search in Google Scholar PubMed

154. Yue, Z, Zhou, Y, Zhao, P, Chen, Y, Yuan, Y, Jing, Y, et al.. p53 Deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5. Leuk Res 2017;60:115–22. https://doi.org/10.1016/j.leukres.2017.07.003.Search in Google Scholar PubMed

155. Upadhyay, P, Sarker, S, Ghosh, A, Gupta, P, Das, S, Ahir, M, et al.. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16. Biomater Sci 2019;7:4325–44. https://doi.org/10.1039/c9bm00912d.Search in Google Scholar PubMed

156. Zhang, B, Wang, X, Deng, J, Zheng, H, Liu, W, Chen, S, et al.. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Lett 2019;459:50–8. https://doi.org/10.1016/j.canlet.2019.05.042.Search in Google Scholar PubMed

157. Yamakuchi, M, Lotterman, CD, Bao, C, Hruban, RH, Karim, B, Mendell, JT, et al.. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 2010;107:6334–9. https://doi.org/10.1073/pnas.0911082107.Search in Google Scholar PubMed PubMed Central

158. Braun, CJ, Zhang, X, Savelyeva, I, Wolff, S, Moll, UM, Schepeler, T, et al.. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008;68:10094–104. https://doi.org/10.1158/0008-5472.can-08-1569.Search in Google Scholar

159. Li, J, Tian, F, Li, D, Chen, J, Jiang, P, Zheng, S, et al.. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression. FEBS Lett 2014;588:3491–500. https://doi.org/10.1016/j.febslet.2014.08.008.Search in Google Scholar PubMed

160. Gandhy, SU, Kim, K, Larsen, L, Rosengren, RJ, Safe, S. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer 2012;12:1–12. https://doi.org/10.1186/1471-2407-12-564.Search in Google Scholar PubMed PubMed Central

161. Li, Y, Choi, PS, Casey, SC, Dill, DL, Felsher, DW. MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell 2014;26:262–72. https://doi.org/10.1016/j.ccr.2014.06.014.Search in Google Scholar PubMed PubMed Central

162. Sun, J, Cai, X, Yung, MM, Zhou, W, Li, J, Zhang, Y, et al.. miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer. Oncogene 2019;38:564–80. https://doi.org/10.1038/s41388-018-0459-x.Search in Google Scholar PubMed PubMed Central

163. Kong, Y, Hu, L, Lu, K, Wang, Y, Xie, Y, Gao, L, et al.. Ferroportin downregulation promotes cell proliferation by modulating the Nrf2–miR-17-5p axis in multiple myeloma. Cell Death Dis 2019;10:1–12. https://doi.org/10.1038/s41419-019-1854-0.Search in Google Scholar PubMed PubMed Central

164. Ren, N, Atyah, M, Chen, W-Y, Zhou, C-H. The various aspects of genetic and epigenetic toxicology: testing methods and clinical applications. J Transl Med 2017;15:1–13. https://doi.org/10.1186/s12967-017-1218-4.Search in Google Scholar PubMed PubMed Central

165. Savale, SK. Genotoxicity of drugs: introduction, prediction and evaluation. Asian J Biomater Res 2018;4:1–29.Search in Google Scholar

166. Li, H-H, Chen, R, Hyduke, DR, Williams, A, Frötschl, R, Ellinger-Ziegelbauer, H, et al.. Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs. Proc Natl Acad Sci USA 2017;114:E10881–9. https://doi.org/10.1073/pnas.1714109114.Search in Google Scholar PubMed PubMed Central

167. Rencüzoğulları, E, Aydın, M. Genotoxic and mutagenic studies of teratogens in developing rat and mouse. Drug Chem Toxicol 2019;42:409–29. https://doi.org/10.1080/01480545.2018.1465950.Search in Google Scholar PubMed

168. Kirkland, D, Kasper, P, Martus, H-J, Müller, L, van Benthem, J, Madia, F, et al.. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests. Mutat Res Genet Toxicol Environ Mutagen 2016;795:7–30. https://doi.org/10.1016/j.mrgentox.2015.10.006.Search in Google Scholar PubMed

169. Mourgues, S, Lomax, ME, O’Neill, P. Base excision repair processing of abasic site/single-strand break lesions within clustered damage sites associated with XRCC1 deficiency. Nucleic Acids Res 2007;35:7676–87. https://doi.org/10.1093/nar/gkm947.Search in Google Scholar PubMed PubMed Central

170. Torgovnick, A, Schumacher, B. DNA repair mechanisms in cancer development and therapy. Front Genet 2015;6:157. https://doi.org/10.3389/fgene.2015.00157.Search in Google Scholar PubMed PubMed Central

171. Li, H-H, Yauk, CL, Chen, R, Hyduke, DR, Williams, A, Frötschl, R, et al.. TGx-DDI, a transcriptomic biomarker for genotoxicity hazard assessment of pharmaceuticals and environmental chemicals. Front Big Data 2019;2:36. https://doi.org/10.3389/fdata.2019.00036.Search in Google Scholar PubMed PubMed Central

172. Magdy, T, Schuldt, AJ, Wu, JC, Bernstein, D, Burridge, PW. Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: opportunities and problems. Annu Rev Pharmacol Toxicol 2018;58:83–103. https://doi.org/10.1146/annurev-pharmtox-010617-053110.Search in Google Scholar PubMed PubMed Central

173. Buick, JK, Moffat, I, Williams, A, Swartz, CD, Recio, L, Hyduke, DR, et al.. Integration of metabolic activation with a predictive toxicogenomics signature to classify genotoxic versus nongenotoxic chemicals in human TK 6 cells. Environ Mol Mutagen 2015;56:520–34. https://doi.org/10.1002/em.21940.Search in Google Scholar PubMed PubMed Central

174. Guo, L, Dial, S, Shi, L, Branham, W, Liu, J, Fang, J-L, et al.. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metabol Dispos 2011;39:528–38. https://doi.org/10.1124/dmd.110.035873.Search in Google Scholar PubMed PubMed Central